Aroa Biosurgery Limited (ASX:ARX)

Revenue by Segment

Financials in millions NZD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Developing, Manufacturing and Selling Soft Tissue Repair Products	103.85M	84.70M	69.07M	63.36M	39.68M
Developing, Manufacturing and Selling Soft Tissue Repair Products Growth	22.62%	22.63%	9.01%	59.68%	77.60%
Total	103.85M	84.70M	69.07M	63.36M	39.68M
Total Growth	22.62%	22.63%	9.01%	59.68%	77.60%

Revenue by Geography

Financials in millions NZD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
United States of America	99.17M	81.19M	66.29M	61.63M	38.60M
United States of America Growth	22.15%	22.47%	7.56%	59.65%	80.52%
Rest of The World	4.68M	3.51M	2.78M	1.73M	1.08M
Rest of The World Growth	33.36%	26.44%	60.56%	60.54%	12.42%
Total	103.85M	84.70M	69.07M	63.36M	39.68M
Total Growth	22.62%	22.63%	9.01%	59.68%	77.60%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 26, 2026

Data Sources Report a data error